Drug & intervention

apixaban

RxCUI 1364430

Clinical trials27
Recruiting6
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

27 shown
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic CancersNCT07493304 · 2026-08-26
RECRUITING
Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer TreatmentNCT07160686 · 2026-04-28
RECRUITING
Apixaban-PK Trial: Preventing Portal Hypertension Complications in CirrhosisNCT07521332 · 2026-04-01
RECRUITING
Apixaban in ThrombocytopeniaNCT06886516 · 2025-02-28
RECRUITING
Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesNCT07270263 · 2024-11-22
RECRUITING
Bariatric Surgery and Pharmacokinetics of ApixabanNCT03448783 · 2018-01-02
RECRUITING
Edoxaban Versus Apixaban in Cancer-Associated Venous ThromboembolismNCT07852637 · 2026-11-01
NOT_YET_RECRUITING
SWITCH: Apixaban vs Vitamin K in HM3NCT07471139 · 2026-08-01
NOT_YET_RECRUITING
Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic DiseaseNCT07713875 · 2026-08-01
NOT_YET_RECRUITING
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTENCT05171049 · 2022-05-05
TERMINATED
Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist DevicesNCT04865978 · 2021-12-14
COMPLETED
Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF TrialNCT04696120 · 2021-03-02
UNKNOWN
Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）NCT04645550 · 2020-11-22
COMPLETED
Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With MedicareNCT04681482 · 2020-11-02
COMPLETED
Pharmacokinetics of Apixaban in Patients Undergoing PancreaticoduodenectomyNCT04191928 · 2020-03-03
COMPLETED
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving DialysisNCT03987711 · 2019-12-10
COMPLETED
Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary EmbolismNCT03988842 · 2019-07-25
TERMINATED
Apixaban for Intrahepatic Non Cirrhotic Portal HypertensionNCT04007289 · 2019-06-24
ACTIVE_NOT_RECRUITING
Apixaban Pharmacokinetics in Bariatric Patients (APB)NCT02406885 · 2017-07-19
COMPLETED
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation TherapyNCT03080883 · 2017-07-14
COMPLETED
Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)NCT02933697 · 2017-06-20
COMPLETED
Drug Interaction Study of Apixaban With Cyclosporine and TacrolimusNCT03083782 · 2017-04-18
COMPLETED
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerNCT02744092 · 2016-12-13
COMPLETED
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial FibrillationNCT02942407 · 2016-12-01
COMPLETED
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismNCT02585713 · 2015-11-20
COMPLETED
ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)NCT02935855 · 2015-09-01
COMPLETED
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) CancerNCT00320255 · 2006-06-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.